Company: COHN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001437749-25-033482
Chunk: 193

Company: Cohen & Co Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 8
Chunk 193
---
 value option was to reduce the burden of monitoring the differences between the cost and the fair value of the Company’s investments, previously classified as available for sale securities, including the assessment as to whether the declines are temporary in nature, and to further remove an element of management judgment.
    
   Such financial assets accounted for at fair value include:
    
     ●   securities that would otherwise qualify for available for sale treatment; 
  ●   investments in equity method affiliates that have the attributes in FASB ASC 946-10-15-2 (commonly referred to as investment companies) or that have fair values that are readily determinable; and 
  ●   investments in residential mortgage loans. 

   The changes in fair value (realized and unrealized gains and losses) of these instruments for which the Company has elected the fair value option are recorded in principal transactions and other income in the consolidated statements of operations. All of the investments for which the Company has elected the fair value option are included as a component of other investments, at fair value in the consolidated balance sheets.
    
   The Company recognized net gains (losses) of ($160,174) and ($10,644), related to changes in fair value of investments that were included as a component of other investments, at fair value during the three months ended  September 30, 2025 and 2024, respectively. The Company recognized net gains (losses) of ($167,503) and ($58,704), related to changes in fair value of investments that were included as a component of other investments, at fair value during the nine months ended  September 30, 2025 and 2024, respectively. 
    
   The Company recognized net gains (losses) of $134 and $7,591, related to changes in fair value of investments that were included as a component of other investments sold, not yet purchased during the three months ended  September 30, 2025 and 2024, respectively. The Company recognized net gains (losses) of $936 and $28,590, related to changes in fair value of investments that were included as a component of other investments sold, not yet purchased during the nine months ended  September 30, 2025 and 2024, respectively.
    
   Fair Value Measurements 
    
   In accordance with FASB ASC 820, the